Another study showed that FOXP3 expression was associated with favorable clinicopathological variables and good prognosis in 182 GC patients and that FOXP3 expression in GC tissues was correlated with less lymphatic invasion and a lower T stage, N stage, and recurrence rate. This evidence concerns the gene FOXP3 and gastric cancer.